We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,988
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTLE
9151
DELISTED
Vital Energy
VTLE
$264K ﹤0.01%
13,397
-24,623
-65% -$317K
MCBC
9152
DELISTED
Macatawa Bank Corp
MCBC
$264K ﹤0.01%
31,457
-9,523
-23% -$73.5K
EXPR
9153
PUT
DELISTED
Express, Inc.
EXPR
$264K ﹤0.01%
14,505
+10,100
+229% +$191K
BV icon
9154
BrightView Holdings
BV
$1.09B
$263K ﹤0.01%
+17,395
New +$238K
CURE icon
9155
Direxion Daily Healthcare Bull 3X ETF
CURE
$187M
$263K ﹤0.01%
3,418
-572
-14% -$39.4K
GB
9156
CALL
DELISTED
Global Blue Group Holding
GB
$263K ﹤0.01%
20,200
-6,800
-25% -$70.9K
HVT icon
9157
CALL
Haverty Furniture Companies
HVT
$449M
$263K ﹤0.01%
+9,500
New +$251K
ICAD
9158
DELISTED
iCAD Inc
ICAD
$263K ﹤0.01%
+19,858
New +$214K
LAB icon
9159
CALL
Standard BioTools
LAB
$280M
$263K ﹤0.01%
43,800
-35,700
-45% -$235K
NMRK icon
9160
CALL
Newmark Group
NMRK
$2.76B
$263K ﹤0.01%
36,108
-9,092
-20% -$56.2K
TXMD icon
9161
TherapeuticsMD
TXMD
$24M
$263K ﹤0.01%
4,347
+573
+15% +$39.1K
RDUS
9162
CALL
DELISTED
Radius Health, Inc.
RDUS
$263K ﹤0.01%
14,700
+1,100
+8% +$16.5K
STL
9163
CALL
DELISTED
Sterling Bancorp
STL
$263K ﹤0.01%
+14,600
New +$220K
CHRS icon
9164
PUT
Coherus Oncology
CHRS
$185M
$262K ﹤0.01%
+15,100
New +$269K
HISF icon
9165
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$99M
$262K ﹤0.01%
5,483
-15,882
-74% -$742K
PRTA icon
9166
PUT
Prothena Corp
PRTA
$455M
$262K ﹤0.01%
+21,800
New +$258K
TITN icon
9167
CALL
Titan Machinery
TITN
$429M
$262K ﹤0.01%
13,400
-1,000
-7% -$17.2K
USNA icon
9168
PUT
Usana Health Sciences
USNA
$247M
$262K ﹤0.01%
+3,400
New +$263K
CFB
9169
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$262K ﹤0.01%
+24,414
New +$235K
WBIT
9170
DELISTED
WBI BullBear Trend Switch US 3000 Total Return ETF
WBIT
$262K ﹤0.01%
13,034
+32
+0.2% +$631
BRG
9171
PUT
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$262K ﹤0.01%
20,700
+8,600
+71% +$82.9K
ATRO icon
9172
CALL
Astronics
ATRO
$4.61B
$261K ﹤0.01%
+23,640
New +$194K
BANR icon
9173
PUT
Banner Corp
BANR
$2.52B
$261K ﹤0.01%
5,600
-1,700
-23% -$70.1K
EVER icon
9174
PUT
EverQuote
EVER
$861M
$261K ﹤0.01%
7,000
-6,100
-47% -$231K
GPRE icon
9175
PUT
Green Plains
GPRE
$1.09B
$261K ﹤0.01%
19,800
+9,200
+87% +$140K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.